The Experts below are selected from a list of 1095 Experts worldwide ranked by ideXlab platform
Jan E Ilkiw - One of the best experts on this subject based on the ideXlab platform.
-
impact of the blood sampling site on time concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of Veterinary Pharmacology and Therapeutics, 2014Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P < 0.05. Following IV Administration, no difference among the sampling sites was found. Following Buccal Administration, maximum concentration [jugular: 6.3 (2.9–9.8), carotid: 3.4 (1.9–4.9), medial saphenous: 2.5 (1.7–4.1) ng/mL], area under the curve [jugular: 395 (335–747), carotid: 278 (214–693), medial saphenous: 255 (188–608) ng·min/mL], and bioavailability [jugular: 47 (34–67), carotid: 32 (20–52), medial saphenous: 23 (16–55)%] were higher in the jugular vein than in the carotid artery and medial saphenous vein. Jugular venous blood sampling is not an acceptable substitute for arterial blood sampling following Buccal Drug Administration.
-
Impact of the blood sampling site on time–concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of veterinary pharmacology and therapeutics, 2013Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P
A R Hedges - One of the best experts on this subject based on the ideXlab platform.
-
impact of the blood sampling site on time concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of Veterinary Pharmacology and Therapeutics, 2014Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P < 0.05. Following IV Administration, no difference among the sampling sites was found. Following Buccal Administration, maximum concentration [jugular: 6.3 (2.9–9.8), carotid: 3.4 (1.9–4.9), medial saphenous: 2.5 (1.7–4.1) ng/mL], area under the curve [jugular: 395 (335–747), carotid: 278 (214–693), medial saphenous: 255 (188–608) ng·min/mL], and bioavailability [jugular: 47 (34–67), carotid: 32 (20–52), medial saphenous: 23 (16–55)%] were higher in the jugular vein than in the carotid artery and medial saphenous vein. Jugular venous blood sampling is not an acceptable substitute for arterial blood sampling following Buccal Drug Administration.
-
Impact of the blood sampling site on time–concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of veterinary pharmacology and therapeutics, 2013Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P
Y Shilo - One of the best experts on this subject based on the ideXlab platform.
-
impact of the blood sampling site on time concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of Veterinary Pharmacology and Therapeutics, 2014Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P < 0.05. Following IV Administration, no difference among the sampling sites was found. Following Buccal Administration, maximum concentration [jugular: 6.3 (2.9–9.8), carotid: 3.4 (1.9–4.9), medial saphenous: 2.5 (1.7–4.1) ng/mL], area under the curve [jugular: 395 (335–747), carotid: 278 (214–693), medial saphenous: 255 (188–608) ng·min/mL], and bioavailability [jugular: 47 (34–67), carotid: 32 (20–52), medial saphenous: 23 (16–55)%] were higher in the jugular vein than in the carotid artery and medial saphenous vein. Jugular venous blood sampling is not an acceptable substitute for arterial blood sampling following Buccal Drug Administration.
-
Impact of the blood sampling site on time–concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of veterinary pharmacology and therapeutics, 2013Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P
Scott D Stanley - One of the best experts on this subject based on the ideXlab platform.
-
impact of the blood sampling site on time concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of Veterinary Pharmacology and Therapeutics, 2014Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P < 0.05. Following IV Administration, no difference among the sampling sites was found. Following Buccal Administration, maximum concentration [jugular: 6.3 (2.9–9.8), carotid: 3.4 (1.9–4.9), medial saphenous: 2.5 (1.7–4.1) ng/mL], area under the curve [jugular: 395 (335–747), carotid: 278 (214–693), medial saphenous: 255 (188–608) ng·min/mL], and bioavailability [jugular: 47 (34–67), carotid: 32 (20–52), medial saphenous: 23 (16–55)%] were higher in the jugular vein than in the carotid artery and medial saphenous vein. Jugular venous blood sampling is not an acceptable substitute for arterial blood sampling following Buccal Drug Administration.
-
Impact of the blood sampling site on time–concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of veterinary pharmacology and therapeutics, 2013Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P
Bruno H Pypendop - One of the best experts on this subject based on the ideXlab platform.
-
impact of the blood sampling site on time concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of Veterinary Pharmacology and Therapeutics, 2014Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P < 0.05. Following IV Administration, no difference among the sampling sites was found. Following Buccal Administration, maximum concentration [jugular: 6.3 (2.9–9.8), carotid: 3.4 (1.9–4.9), medial saphenous: 2.5 (1.7–4.1) ng/mL], area under the curve [jugular: 395 (335–747), carotid: 278 (214–693), medial saphenous: 255 (188–608) ng·min/mL], and bioavailability [jugular: 47 (34–67), carotid: 32 (20–52), medial saphenous: 23 (16–55)%] were higher in the jugular vein than in the carotid artery and medial saphenous vein. Jugular venous blood sampling is not an acceptable substitute for arterial blood sampling following Buccal Drug Administration.
-
Impact of the blood sampling site on time–concentration Drug profiles following intravenous or Buccal Drug Administration
Journal of veterinary pharmacology and therapeutics, 2013Co-Authors: A R Hedges, Bruno H Pypendop, Y Shilo, Scott D Stanley, Jan E IlkiwAbstract:The aim of this study was to examine the effect of the sampling site on the Drug concentration–time profile, following intravenous or Buccal (often called ‘oral transmucosal’) Drug Administration. Buprenorphine (20 μg/kg) was administered IV or Buccally to six cats. Blood samples were collected from the carotid artery and the jugular and medial saphenous veins for 24 h following buprenorphine Administration. Buprenorphine concentration–time data were examined using noncompartmental analysis. Pharmacokinetic parameters were compared using the Wilcoxon signed rank test, applying the Bonferroni correction. Significance was set at P
